2017-2019年236个国家慢性病综合防控示范区建设质量评估  

Evaluation on the quality of 236 National Demonstration Areas for comprehensive prevention and control of chronic diseases betweem 2017 and 2019

作　　者：董文兰[1] 毛凡[1] 姜莹莹[1] 夏章 张伟伟[1] 董建群[1] 刘世炜[1] 周脉耕[1] 吴静[1] Dong Wenlan;Mao Fan;Jiang Yingying;Xia Zhang;Zhang Weiwei;Dong Jianqun;Liu Shiwei;Zhou Maigeng;Wu Jing(National Center for Chronic and Non-communicable Disease Control and Prevention/Tobacco Control Office,Chinese Center for Disease Control and Prevention,Beijing 100050,China)

机构地区：[1]中国疾病预防控制中心慢性非传染性疾病预防控制中心/控烟办公室,北京100050

出　　处：《中华流行病学杂志》2021年第8期1413-1419,共7页Chinese Journal of Epidemiology

基　　金：国家重点研发计划(2018YFC1315304)。

摘　　要：目的评估国家慢性病综合防控示范区(示范区)的建设质量。方法利用2017-2019年期间国家慢性病综合防控示范区现场调研评估结果,统计各指标的得分,比较不同指标间、不同区域间得分的差异。采用x±s描述各指标的得分情况,得分值的95%CI检验不同区域示范区得分的统计学差异。为了比较不同指标间的得分情况,将各指标得分换算成百分制得分。结果236个示范区现场评估的百分制总得分83.5分;一级指标层面,得分由高到低依次为体系整合(92.8)、政策完善(90.3)、环境支持(88.4)、健康教育与健康促进(87.4)、慢性病全程管理(78.1)、创新引领(76.5)、监测与评估(75.1)。东部示范区总得分(259.2±18.8),高于中部(243.2±15.2)和西部(245.4±19.7),差异有统计学意义。结论示范区建设质量在东部、中部和西部间存在差异,这些差异在公共卫生政策制定和资源配置时应予以充分考虑;慢性病全程管理、监测与评估和创新引领维度是示范区建设的薄弱环节,应在下一步示范区建设中进一步加强。Objective To evaluate the quality of the National Demonstration Area for Comprehensive Prevention and Control of NCDs(referred to as"the Demonstration Area").Methods Based on the evaluation scores of the Demonstration Area field survey from 2017 to 2019,we counted the scores of each indicator,comparing the scores among indicators and regions.x±s was used to describe the scores.The 95%CI of the score was used to test the statistical difference among regions.Each score was converted into a hundred-mark system to compare the scores among indicators.Results Of 236 Demonstration Areas,the total score was 83.5.The scores of the first-level indicator listed from high to low appeared as Integrating System of NCD Prevention and Control(92.8),Policy Perfection(90.3),Building Supportive Environment for NCD Prevention and Control(88.4),Implementation of Health Education and Health Promotion(87.4),Whole-course Management of NCDs(78.1),Innovation and Guidance(76.5),Surveillance and Evaluation(75.1).Total scores were higher in the east(259.2±18.8)comparing to the middle(243.2±15.2)or the west(245.4±19.7)regions.Conclusions Substantial variations on the quality in the Demonstration Area existed across different regions in China.These disparities are important to the government when developing health policies and allocating resources.Whole-course Management of NCDs,Surveillance and Evaluation,and Innovation and Guidance in the Demonstration Area also needs to be improved.

关 键 词：慢性病 示范区 现场调研 评估 

分 类 号：R197.1[医药卫生—卫生事业管理]